GlassScriptPhysician profile
Anthony Digianfilippo
NPI 1629078761
$1,559.16
in general payments reported to CMS, 2019-2025
19 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $31.11 · 2021: $479 · 2022: $222 · 2023: $235 · 2024: $307 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $578.54 | 2019-2024 | Yukon Oct Spinal System, Ozark Cervical Plate System, Core |
| Olympus America INC. | $148.72 | 2021 | |
| Zimvie INC. | $140.71 | 2024 | |
| Globus Medical, INC. | $124.93 | 2021 | |
| Depuy Synthes Sales INC. | $121.54 | 2025 | Velys |
| Medtronic, INC. | $108.27 | 2021 | |
| Abbott Laboratories | $59.92 | 2021 | |
| Genzyme Corporation | $35.44 | 2023 | |
| Ucb, INC. | $35.09 | 2023 | |
| Lilly USA, LLC | $29.60 | 2023 | Emgality, Reyvow |
| Biogen, INC. | $26.57 | 2025 | Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $24.98 | 2019 | |
| Genentech USA, INC. | $23.67 | 2025 | Ocrevus Zunovo |
| Supernus Pharmaceuticals, INC. | $22.39 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.64 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.80 | 2022 | |
| Amgen INC. | $14.57 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $13.88 | 2023 | Spritam |
| Emd Serono, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Digianfilippo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.